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Pain Management in Long-Term
Care: Update on Guidelines and
JCAHO Standards
Chronic pain is expensive-not only
economically, but in the loss of plea-
sure and the ability to lead a normal
productive life-and it only gets worse
with age. New research promises that
new guidelines for pain management
will become available. Awareness of the
current guidelines aids elder law practi-
tioners in advising clients about their
apparent circumstances and needs.
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hronic pain is the most expensive
health problem in the United States,
costing about $65 billion annually. The
costs are due to direct medical expens-
es, lost income, lost productivity, and
legal charges.1 This is not surprising, since unre-
lieved chronic pain can have serious consequences,
such as the development of depression, decreased
socialization, sleep disturbances, impaired ambula-
tion, and increased health care costs and utiliza-
tion. Many other conditions may potentially be
worsened by the presence of pain, such as gait dis-
turbances, progress of rehabilitation, decondition-
ing, polypharmacy, cognitive dysfunction, and mal-
nutrition.2
Careful attention must be given to the identifi-
cation and assessment of pain, especially in the
elderly population, since chronic pain is a common
finding.' Older people are more likely to be affect-
ed by arthritis, bone and joint disorders, back
problems, and various other chronic conditions
that cause pain.
Fortunately, the issue of pain management has
been drawing much attention in the recent years.
Newer guidelines have been published that address
many aspects of pain management, from initial
assessment through long-term follow-up.
American Geriatrics Society
In 1998, the American Geriatrics Society (AGS)
published a consensus statement regarding pain
management guidelines for the elderly.4 These
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guidelines specifically address the management of
chronic, noncancer pain in older persons. Such a
paper was needed because prior to its publication,
there were no comprehensive recommendations
from such a large panel of experts. The AGS tried
to avoid duplicating past efforts and, as a result,
has created a very useful guide for anyone faced
with the challenge of managing chronic pain in an
older person.
One of the most important issues addressed by
the AGS guidelines is that of assessing pain in the
elderly. Older patients should be assessed for evi-
dence of chronic pain whenever they present to a
health care service. When assessing pain, it is
important to bear in mind that older patients may
use descriptors such as "gnawing," or "aching,"
rather than using the actual word "pain." For this
reason, a variety of descriptors synonymous with
pain should be used.
It is imperative that the clinician that assesses
an older patient for pain acknowledges potential
barriers to effective pain management. Barriers that
are specific to older patients include reluctance to
report pain despite an impact on function, fear of
the significance of pain, fear of the medications
used to treat pain, or the belief that pain is a pun-
ishment for some wrongdoing.
If a clinician believes that some of these barriers
are present, he or she should seek assistance from
the appropriate health care professional to address
the issue. For example, a patient who is fearful of
the side effects of an analgesic medication will like-
ly benefit from speaking with a physician or phar-
macist. In such instances, the long-term care setting
offers an ideal environment for disease-state man-
agement because long-term care facilities are
required to utilize an interdisciplinary approach to
patient care.
The AGS guidelines also address pharmacolog-
ical issues relevant to the elderly population. Older
patients are more likely to experience adverse drug
events; however, this fact should not prohibit the
use of analgesic or adjuvant medications in elderly
patients. The elderly can safely use most medica-
tions when started at lower doses that are then
slowly increased to reach the effective dosage.
Pharmacotherapeutic strategies are most effec-
tive when combined with nonpharmacolgical treat-
ments. Furthermore, it may be advantageous to use
a combination of low doses of analgesic agents
from different drug classes, rather than using high
doses of one single agent. An example of this
would be the use of an opioid with a non-steroidal
anti-inflammatory agent (NSAID). This use of mul-
tiple medications to achieve the same therapeutic
endpoint, or polypharmacy, is a practice that most
clinicians usually try to avoid. However, polyphar-
macy may be necessary to minimize the side effects
of individual agents.
The majority of pain management guidelines
will recommend utilizing the World Health
Organization (WHO) analgesic ladder.5 This is a
stepwise approach to pain management that uti-
lizes a 3-step ladder of increasing analgesia. The
first step of the ladder recommends using non-opi-
oid analgesics, such as acetaminophen or NSAIDs,
with or without the use of adjuvant medications,
such as corticosteroids or antidepressants.
The use of NSAIDs in the elderly is of para-
mount concern. The chronic use of NSAIDs in the
elderly has been associated with a high incidence of
adverse effects.' The risk of gastrointestinal bleed-
ing associated with NSAID use increases with age.
The AGS guidelines recommend extreme caution
when using NSAIDs in the elderly. In fact, the AGS
recommends avoiding high-dose, long-term NSAID
use in the elderly. When NSAIDs must be used
chronically, it is recommended that they be given as
needed, rather than scheduled daily or around-the-
clock. This concept differs from one of the basics of
managing chronic pain. That is, when treating
chronic pain, the intention is to prevent pain, not
chase it. However, when considering the risks of
chronic NSAID use in the elderly, the risks may
outweigh the benefits, and alternative non-opioid
medications may be more appropriate.
Acetaminophen is considered the drug of choice
for managing mild to moderate musculoskeletal
pain. Acetaminophen, however, also has properties
that must be taken into consideration when it is
prescribed. The main concern with the use of aceta-
minophen is the potential for liver toxicity. This
concern limits the maximum daily dose to 4 grams.
Clinicians must remember that certain opioid med-
ications are combination products containing
acetaminophen (e.g., Vicodin®, Percocet®), and
must not dose the opioid/non-opioid combination
product in a way that would exceed the 4-gram per
day acetaminophen limit.
The use of opioids in noncancer pain has been
a controversial topic. Nevertheless, patients should
receive adequate analgesia regardless of their diag-
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noses. The doses of opioid analgesics needed for
managing chronic pain that is noncancer related
are often lower than those needed for managing
cancer-related pain.
Adjuvant medications may be helpful for man-
aging chronic pain that is neuropathic in quality, in
addition to the use of analgesic medications.'
Adjuvant medications that are commonly used
include antidepressants, anticonvulsants, antiar-
rhythmics, and various others. Many drugs from
each of these classes can safely be used in the elder-
ly, provided that attention is given to monitoring
for side effects. Of particular interest is the class of
antidepressants.
The antidepressants most commonly used for
managing pain are amitriptyline, nortriptyline,
imipramine, and desipramine. All have similar
analgesic effects, however each has a very different
side-effect profile. For example, amitriptyline is
converted in the body to nortriptyline. Both have
the same analgesic potential, however, amitripty-
line is associated with more pronounced anti-
cholinergic effects (dry mouth, constipation, seda-
tion).' As a result, amitriptyline is not recommend-
ed for use in the elderly, and nortriptyline can be
used in its place.!
American Medical Director's Association
In 1999, the American Medical Director's
Association (AMDA) published a clinical practice
guideline for the management of chronic pain in
the long-term care setting.1" The guideline was
developed by an interdisciplinary team utilizing
evidence-based and consensus-based medicine. One
of the goals of the AMDA was to promote respon-
sible and competent physician practices within the
long-term care setting. Similar to the AGS guide-
line, this publication focuses on many aspects of
the management of chronic pain.
Firstly, the AMDA stresses the importance of
recognizing the barriers to identifying chronic pain
in the long-term care setting. Such barriers include
blunted responses to pain, cognitive and communi-
cation barriers, cultural and social barriers, coex-
isting illnesses and multiple medication use, staff
training and access to appropriate tools, and sys-
tem-related barriers.
Managing pain for cognitively impaired patients
presents a considerable challenge. Such patients
have been found to be at higher risk for the under-
treatment of pain. Furthermore, patients may be
diagnosed with a mood or thought disorder and
consequently treated with psychotropic medication
when their real problem is unrecognized and
untreated pain. Clinicians should also realize that a
specific cause of the chronic pain might not be iden-
tifiable. The AMDA states that pain must always be
treated, even when its cause is not known.
Secondly, the AMDA presents a stepwise
approach for pain management. The first step
involves identifying pain. Use of the Minimum Data
Set (MDS) is proposed as a tool for identifying the
presence of pain. In addition to the section of the
MDS that specifically addresses pain, other sections
may identify nonverbal signs of pain. These may
include sleep cycle disruptions; sad, apathetic, or
anxious appearance; change in mood; change in
behavior; functional limitations; change in activities
of daily living function; weight loss; or change in
sense of initiative or involvement, to name a few.
The next step in providing pain management, as
outlined by the AMDA, involves the actual provi-
sion of treatment. This involves taking a compre-
hensive history and performing a physical exam,
including further diagnostic testing if necessary. It
also is recommended to obtain consults from any
pertinent services and to utilize an interdisciplinary
approach when designing the resident's care plan.
The recommendations for use of analgesic
agents are very similar to those of the AGS; how-
ever, the AMDA lists certain medications that
should be avoided in long-term care residents. Such
agents include indomethacin, piroxicam, tolmetin,
meclofenamate, propoxyphene, meperidine, penta-
zocine, and butorphanol. Use of these medications
is not recommended due to the increased incidence
of adverse reactions without additional therapeutic
benefit over other, more appropriate agents.
Lastly, pain should be assessed at regular inter-
vals or, at minimum, whenever a change in condi-
tion prompts a new MDS to be completed.
Joint Commission on Accreditation of
Healthcare Organizations
In addition to these updated guidelines, standards
of patient care have been updated, with a new
focus on pain management. The Joint Commission
on Accreditation of Healthcare Organizations
(JCAHO) updated its standards for accreditation in
1999.11 The issue of pain management was
addressed for ambulatory patient care, behavioral
health care, home care, health care networks, hos-
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pital, long-term care, and long-term care pharma-
cies. These standards will appear in the 2000-2001
accreditation standards manuals, and facilities will
first be assessed for implementation of these stan-
dards in 2001. The updated standards create new
expectations for the assessment and management
of pain with a focus on patient goals and rights.
Of particular interest are the standards for the
long-term care setting. The first topic addressed is
that of the residents' rights and ethical issues
involved in providing care. Long-term care facili-
ties must address the effective management of pain
by including the resident when making decisions
regarding care. An example of how this might be
implemented would be for a facility to include a
commitment to pain management in its resident bill
of rights. It is also acceptable to expect the resi-
dents to assist in this commitment to pain manage-
ment by being actively involved in the management
process. This includes asking what to expect
regarding pain management, discussing therapeutic
options with health care providers, working with
the providers to develop a pain management plan,
asking for pain-relief intervention when pain first
begins, helping the staff to assess pain, and notify-
ing the staff if the pain is not relieved.
JCAHO has also set the standard that all resi-
dents have the right to appropriate assessment and
management of pain. Long-term care facilities must
plan, support, and coordinate activities and
resources to assure that pain of any resident is rec-
ognized and addressed appropriately. This includes
the initial assessment and regular reassessment of
pain, the education of providers in pain manage-
ment, the education of the residents and their fam-
ilies, the management of pain and the side effects of
pain treatments, and the consideration of personal,
cultural, spiritual, and ethnic beliefs that may
impact care. For example, pain could be considered
the "fifth" vital sign, where pain ratings are record-
ed with temperature, pulse, respiration, and blood
pressure. Many facilities have already adopted this
approach to pain assessment and documentation.
Long-term care facilities must prepare for con-
tinuity of care after discharge and help the resident
and the family to adapt to the resident's care plan.
Discharge planning must address several areas of
patient care; however, the new standards direct
attention to the management of symptoms, such as
pain or nausea. The resident should have a dis-
charge regimen addressing symptoms that is practi-
cal for that resident and his or her caregiver.
One very important standard of the JCAHO
guidelines is the concept of providing individualized
care. With regard to pain management, there are
now resources that help guide the decision-making
process or present pain management in a protocol
or pathway format. Pain is one of the most subjec-
tive disease states, requiring great attention to the
resident's reports and complaints. There are no
objective biologic markers for pain, especially for
chronic pain. Furthermore, there are several differ-
ent published tools for assessing pain. However, it's
important to recognize that individual patients will
require, or prefer, to use specific tools. For example,
one patient may not be able to use a visual analogue
scale and may prefer a numerical rating scale
instead. Yet another patient may prefer the "smiling
faces" scale. It may not be reasonable to select one
or two scales and expect every resident in a given
facility to be able to use them.
Lastly, long-term care facilities must educate
residents to the concept that pain management is a
part of their treatment. Residents and family mem-
bers should be instructed about pain, the risk of
pain, and the importance of pain management. For
example, the facility could provide information to
all residents and families about pain at the time of
admission. The JCAHO standards also provide
suggestions for the information that should be
included in such educational literature.
Chronic pain continues to be an under-diag-
nosed and under-treated problem, especially in the
elderly. Elderly patients residing in long-term care
facilities are at particular risk for developing com-
plications from poorly managed chronic pain. By
utilizing a multidisciplinary approach to managing
pain and practicing according to nationally recog-
nized treatment guidelines, the long-term care facil-
ity may become the best-equipped setting for the
management of chronic pain.
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